About

Richard Joye co-founded SeriTech in 2016 with two other partners and currently leads all business activities as Managing Director. Mr Joye is a consulting and investment professional, experienced in investments and venture development. He has led and executed dozens of transactions in various sectors, with a focus on disruptive, industry-shaping technologies.

Mr Joye began his career at Arthur Andersen & Company (Geneva, Switzerland), followed by a succession of investment boutiques in Switzerland, the Middle East and Asia. His skills combine financial expertise, management and business development. He has developed a sound knowledge in life science.

Mr Joye is a Swiss national now based in Barcelona, with global exposure and network.

Contributions

EARLY INSIGHT

SERITECH LEVERAGES FAST-DETACHING, DISSOLVING MICRONEEDLE FOR TRANSDERMAL DRUG DELIVERY

Richard Joye and Tim Morch discuss the advantages of using dissolvable microneedles for the delivery of vaccines, particularly in regards to storage and transport, and introduce SeriTech’s fast-detaching dissolvable microneedle technology.